{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:26:20Z","timestamp":1791087980441,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.07.037","type":"journal-article","created":{"date-parts":[[2007,8,8]],"date-time":"2007-08-08T11:20:09Z","timestamp":1186572009000},"page":"7261-7270","source":"Crossref","is-referenced-by-count":29,"title":["Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid"],"prefix":"10.1016","volume":"25","author":[{"given":"I.A.F.B.","family":"Silveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Laranjeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.F.","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.R.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Frasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Jessouroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.07.037_bib1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.07.037_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.037_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine","volume":"181","author":"Richmond","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.037_bib4","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomized, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CDLI.11.1.83-88.2004","article-title":"Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A\/C polysaccharide vaccination in Saudi Arabia","volume":"11","author":"Jokhdar","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.40.1.245-256.1983","article-title":"Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide\u2013protein conjugates","volume":"40","author":"Chu","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302-317.2000","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2007.07.037_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.037_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants","volume":"174","author":"Fairley","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.037_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide\u2013protein conjugate vaccine","volume":"175","author":"Leach","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.037_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2007.07.037_bib12","unstructured":"Report of the Committee on Safety of Medicines Expert Working Group on Meningococcal Group C Conjugate Vaccines; 2002. http:\/\/www.mca.gov.uk\/ourwork\/monitorsafequalmed\/safetymessages\/mencwgreport.pdf (accessed January 14, 2004)."},{"key":"10.1016\/j.vaccine.2007.07.037_bib13","unstructured":"National Disease Surveillance Centre in collaboration with the Irish Meningococcal and Meningitis Reference Laboratory. Enhanced surveillance of bacterial meningitis including meningococcal septicaemia, in Ireland, Annual 2003\u2014provisional figures 2004. http:\/\/www.ndsc.ie\/Publications\/BacterialMeningitisReports\/d985.pdf (accessed June 6, 2004)."},{"key":"10.1016\/j.vaccine.2007.07.037_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0264-410X(02)00589-3","article-title":"Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain","volume":"21","author":"Salleras","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0264-410X(02)00590-X","article-title":"Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine","volume":"21","author":"Salleras","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib16","first-page":"22","article-title":"Meningitis group C vaccination campaign in the Netherlands","volume":"12","author":"Timen","year":"2002","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.vaccine.2007.07.037_bib17","unstructured":"Division of Bacteriology, Scientific Institute of Public Health. Report of Neisseria meningitides National Surveillance centre. Belgium; 2002, 2003. http:\/\/www.iph.fgov.be\/bacterio\/iframes\/rapports\/2002\/Men_2002_Fr.pdf (accessed January 6, 2004)."},{"key":"10.1016\/j.vaccine.2007.07.037_bib18","series-title":"Australian immunization handbook","year":"2003"},{"key":"10.1016\/j.vaccine.2007.07.037_bib19","unstructured":"Canadian Paediatric Society. Routine Immunization Schedule; 2004. http:\/\/www.cps.ca\/english\/statements\/ID\/PIDNotesImmunization.htm (accessed October 16, 2004)."},{"key":"10.1016\/j.vaccine.2007.07.037_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","article-title":"Meningococcal polysaccharide\u2013protein conjugate vaccines","volume":"5","author":"Snape","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.037_bib21","unstructured":"Ministry of Health, National Foundation of Health. CENEPI: Brazil; 2003."},{"key":"10.1016\/j.vaccine.2007.07.037_bib22","first-page":"41","article-title":"The hyperferremic mouse model for the evaluation of the effectiveness of VA-MENGOC-BC against Neisseria meningitidis B clinical isolates","volume":"28","author":"Sifontes","year":"1997","journal-title":"Arch Med Res"},{"key":"10.1016\/j.vaccine.2007.07.037_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","article-title":"Immunochemistry of groups A, B, and C meningococcal polysaccharide\u2013tetanus toxoid conjugates","volume":"127","author":"Jennings","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib25","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0264-410X(99)00336-9","article-title":"Preparation of pneumococcal capsular polysaccharide\u2013protein conjugate vaccines utilizing new fragmentation and conjugation technologies","volume":"18","author":"Pawlowski","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.vaccine.2005.08.096","article-title":"Versatile and efficient synthesis of protein\u2013polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry","volume":"24","author":"Lees","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib27","unstructured":"Lee Che-HR, Frasch CE. Polysaccharide\u2013protein conjugate vaccines. Patent pending, US 60\/493, 389; WO 2005\/014,037 A2; 2005."},{"key":"10.1016\/j.vaccine.2007.07.037_bib28","unstructured":"Jessouroun E, da Silveira IAFB, Bastos RC, Frasch CE, Lee Che-HR. Process for preparing polysaccharide\u2013protein conjugate vaccines. International Publication WO 2005\/037320; 2005."},{"key":"10.1016\/j.vaccine.2007.07.037_bib29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. III. Preparation and immunochemical properties of the group A, group B and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.07.037_bib30","unstructured":"World Health Organization. Requirements for meningococcal polysaccharide vaccine. Technical Report Series, No. 658; 1981."},{"key":"10.1016\/j.vaccine.2007.07.037_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","article-title":"Quantitative estimation of sialic acids","volume":"24","author":"Svennerholm","year":"1957","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2007.07.037_bib32","first-page":"143","article-title":"Physicochemical studies of the structure and stability of polysaccharide\u2013protein conjugate vaccines","volume":"87","author":"Jones","year":"1996","journal-title":"Dev Biol Stand Basel Karger"},{"key":"10.1016\/j.vaccine.2007.07.037_bib33","unstructured":"World Health Organization. Recommendations for the production and control of meningococcal group C conjugate vaccines. WHO Technical Report, Series No. 924; 2004."},{"key":"10.1016\/j.vaccine.2007.07.037_bib34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.vaccine.2003.08.040","article-title":"Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines","volume":"22","author":"J\u00f3dar","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib35","unstructured":"World Health Organization. Requirements for diphtheria, tetanus, pertussis and combined vaccines. WHO Technical Report Series No. 800; 1990."},{"key":"10.1016\/j.vaccine.2007.07.037_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2007.07.037_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/abio.1996.0048","article-title":"A rapid formaldehyde assay using Purpald Reagent: application under periodation conditions","volume":"234","author":"Quensenberry","year":"1996","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2007.07.037_bib38","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide\u2013diphtheria toxoid conjugate vaccines","volume":"103","author":"Lei","year":"2000","journal-title":"Dev Biol Basel Karger"},{"key":"10.1016\/j.vaccine.2007.07.037_bib39","series-title":"Water determination by Karl Fischer Titration. Theory and applications","author":"Wieland","year":"1987"},{"key":"10.1016\/j.vaccine.2007.07.037_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2005.04.002","article-title":"Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide","volume":"33","author":"Park","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2007.07.037_bib41","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicentre comparison of Neisseria meningitides serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib42","series-title":"Immunochemistry. 2. A practical approach","first-page":"31","article-title":"Simple solid phase assays of avidity","author":"Goldblatt","year":"1997"},{"key":"10.1016\/j.vaccine.2007.07.037_bib43","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib44","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(19)41784-5","article-title":"Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance","volume":"250","author":"Bhattacharjee","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.07.037_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0008-6215(96)00253-4","article-title":"Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production","volume":"296","author":"Lemercinier","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2007.07.037_bib46","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0731-7085(02)00462-4","article-title":"Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture","volume":"30","author":"Jones","year":"2002","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.vaccine.2007.07.037_bib47","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vaccine.2005.05.041","article-title":"Relationships among physico-chemical and biological tests for a synthetic Hib\u2013TT conjugate vaccine","volume":"25","author":"Cuervo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/IAI.41.2.609-617.1983","article-title":"Immunological evaluation of meningococcal group C polysaccharide\u2013tetanus toxoid conjugate in mice","volume":"41","author":"Beuvery","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2005.01.129","article-title":"Mucosal immune responses to meningococcal C polysaccharide\u2013protein conjugate in mice","author":"Cuello","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib51","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0264-410X(02)00625-4","article-title":"Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling","volume":"21","author":"Wang","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.femsim.2004.07.003","article-title":"Memory immune response generated in Cercopithecusaethiops against meningococcal polysaccharide serogroup C conjugate vaccine","volume":"43","author":"Carmenate","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib54","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: re-evaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib55","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection-serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib56","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.vaccine.2006.11.029","article-title":"New meningococcal C polysaccharide\u2013tetanus toxoid conjugate. Physico-chemical and immunological characterization","volume":"25","author":"Cuello","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/IAI.72.1.187-195.2004","article-title":"Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria","volume":"72","author":"Ritcher","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0928-8244(03)00346-8","article-title":"Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide\u2013P64K protein conjugates","volume":"40","author":"Carmenate","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib59","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/IAI.71.6.3402-3408.2003","article-title":"Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitides\u2013diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-1759(97)00059-8","article-title":"Correlation between the avidity of mouse\u2013human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA)","volume":"205","author":"McCloskey","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2007.07.037_bib61","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","article-title":"Comparison of functional immune responses in humans after intranasal and intramuscular immunizations with outer membrane vesicle vaccines against group B meningococcal disease","volume":"21","author":"Aase","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.037_bib62","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/1521-4141(2000)30:8<2226::AID-IMMU2226>3.0.CO;2-5","article-title":"Antigen persistence is required for somatic mutation and affinity maturation of immunoglobulin","volume":"30","author":"Wang","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2007.07.037_bib63","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.037_bib64","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.vaccine.2004.02.014","article-title":"PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children","volume":"22","author":"Vermont","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T18:30:24Z","timestamp":1684002624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07007943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":64,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07007943"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}